Benjamin G. Bitler

5.6k citations

100 papers · 3.9k indexed · 1 hit paper · h-index 34

Impact in

Cancer Research top 2%
Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment

Papers in

Reproductive Medicine 17
- Ovarian cancer diagnosis and treatment 17
Biological Psychiatry 3

Co-authors: Rugang Zhang Andrew V. Kossenkov Katherine M. Aird José R. Conejo-García David W. Speicher Kian Behbakht Joyce A. Schroeder Zachary L. Watson
Journals: Molecular Cancer Research (8 papers)Gynecologic Oncology (7 papers)Cell Reports (5 papers)Molecular Carcinogenesis (5 papers)Cancer Research (5 papers)
Partner nations: United States Russia Mexico

In The Last Decade

Benjamin G. Bitler

93 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers 2015 · 492 citations

Peers

Countries citing papers authored by Benjamin G. Bitler

Since Specialization

Citations

This map shows the geographic impact of Benjamin G. Bitler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin G. Bitler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin G. Bitler more than expected).

Fields of papers citing papers by Benjamin G. Bitler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin G. Bitler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin G. Bitler. The network helps show where Benjamin G. Bitler may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Benjamin G. Bitler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin G. Bitler Line = papers co-authored together Benjamin G. Bitler links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Mutant p53 binds and controls estrogen receptor activity to drive endocrine resistance in ovarian cancer Genes & Development ·A Vinoth, Eurys Rolant, Jen-Rong Lee, Ameenathul M. Fawzy, Giulia De Sarlo, O. Garzón Peña, Julia I-Ju Leu, И.С. КОВАЛЕВ, Anne‐Marie Mes‐Masson, Jennifer Sims‐Mourtada, Noam Auslander, Ronny Drapkin, Benjamin G. Bitler, Nan Zhang, Maureen E. Murphy	2025	1
2	Tumor-Intrinsic Activity of Chromobox 2 Remodels the Tumor Microenvironment in High-grade Serous Carcinoma Cancer Research Communications ·Ritsuko Iwanaga, Tomomi M. Yamamoto, سحر دخت محمد, Lily L. Nguyen, Elizabeth R. Woodruff, (unknown), Zhi Jun Cai, Etienne Danis, Thomas Danhorn, Meher P. Boorgula, Siddhartha S. Mitra, Nicole A. Marjon, Benjamin G. Bitler, Lindsay W. Brubaker	2024	1
3	Claudin-4 Modulates Autophagy via SLC1A5/LAT1 as a Mechanism to Regulate Micronuclei Cancer Research Communications ·Marshall W. Carter, Julie Lang, Fredrick J. Rosario, Siti Hafizah Suaidi, Patricia Webb, Margaret Neville, Elizabeth R. Woodruff, Benjamin G. Bitler	2024	6
4	Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell Survival Cancer Research Communications ·Marshall W. Carter, Julie Lang, Siti Hafizah Suaidi, Kian Behbakht, Mar�a In�s Vera, Patricia Webb, Kenneth P. Nephew, Margaret Neville, Elizabeth R. Woodruff, Benjamin G. Bitler	2024	3
5	Targeting Tryptophan Catabolism in Ovarian Cancer to Attenuate Macrophage Infiltration and PD-L1 Expression Cancer Research Communications ·Miguel-Angel Feliz Martínez, 黄洁, YU Ying-yu, (unknown), Mike Bickerdike, K. P. Datla, M Spalla, Kimberly R. Jordan, Bradley R. Corr, Nicole A. Marjon, Elizabeth R. Woodruff, Jennifer K. Richer, Benjamin G. Bitler	2024	9
6	Targeting DUSP Activity as a Treatment for High-Grade Serous Ovarian Carcinoma Molecular Cancer Therapeutics ·Emine Tuğba Alataş, Tomomi M. Yamamoto, Alexandra McMellen, Elizabeth R. Woodruff, H R MALLOY, (unknown), Benjamin G. Bitler	2022	11
7	Expression and T cell regulatory action of the PD‐1 immune checkpoint in the ovary and fallopian tube American Journal of Reproductive Immunology ·Joshua Johnson, So‐Youn Kim, بهزاد سهیلی, Rengasamy Asokan, Черников Алексей Николаевич, Elise S. Bales, 鍾吾大屋, Gianmarco De Francisc iMorales, Amanda N. Kallen, Liesl Nel‐Themaat, Alex J. Polotsky, (unknown), David J. Orlicky, Kimberly R. Jordan, Benjamin G. Bitler	2022	4
8	TWEAK–Fn14–RelB Signaling Cascade Promotes Stem Cell–like Features that Contribute to Post-Chemotherapy Ovarian Cancer Relapse Molecular Cancer Research ·野坂祐子, Carolina Souto dos Santos, Samuel F. Gilbert, Tahyah Hidjaz, Jennifer A. Waters, 藤永明, Rehana de Vries, D. Benati, Melissa Szocik, Ela Kurniasari, 谭立, پورسیاه ناوی سامان, P. Efstratiou, Benjamin G. Bitler, Tom Huxford, Carrie D. House	2022	14
9	Loss of Claudin-4 Reduces DNA Damage Repair and Increases Sensitivity to PARP Inhibitors Molecular Cancer Therapeutics ·Tomomi M. Yamamoto, Patricia Webb, Dana M. Davis, Heidi K. Baumgartner, Elizabeth R. Woodruff, Saketh R. Guntupalli, Margaret Neville, Kian Behbakht, Benjamin G. Bitler	2022	11
10	The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval Clinical Cancer Research ·Kimberly R. Jordan, Matthew J. Sikora, Jill E. Slansky, Christoph M. Volz, Jennifer K. Richer, G Giomataris, Junxiao Hu, Rebecca J. Wolsky, Zachary L. Watson, Tomomi M. Yamamoto, James C. Costello, Aaron Clauset, Kian Behbakht, S. Mavinamne, Benjamin G. Bitler	2020	40
11	Targeting Fatty Acid Oxidation to Promote Anoikis and Inhibit Ovarian Cancer Progression Molecular Cancer Research ·Austin Dada, Lubna Qamar, Tomomi M. Yamamoto, Alexandra McMellen, Zachary L. Watson, Jennifer K. Richer, Kian Behbakht, Isabel R. Schlaepfer, Benjamin G. Bitler	2020	86
12	Ovarian Tumor Cell Expression of Claudin-4 Reduces Apoptotic Response to Paclitaxel Molecular Cancer Research ·Apri Cahyo Diwantoro, Douglas A. Hicks, Patricia Webb, D H Allison, Benjamin G. Bitler, Kian Behbakht, Heidi K. Baumgartner	2019	22
13	Amplification of the Mutation-Carrying BRCA2 Allele Promotes RAD51 Loading and PARP Inhibitor Resistance in the Absence of Reversion Mutations Molecular Cancer Therapeutics ·Pyoung Hwa Park, Tomomi M. Yamamoto, Hua Li, Allen L. Alcivar, Bing Xia, Yifan Wang, Andrea J. Bernhardy, Kristen M. Turner, Andrew V. Kossenkov, Zachary L. Watson, Kian Behbakht, Silvia Casadei, Elizabeth M. Swisher, Paul S. Mischel, Neil Johnson, Benjamin G. Bitler	2019	20
14	Activation of Wnt signaling promotes olaparib resistant ovarian cancer Molecular Carcinogenesis ·Tomomi M. Yamamoto, Alexandra McMellen, Zachary L. Watson, 和宏樫尾, Susan Holland, Elmar Nurmemmedov, Tanay Thakar, George‐Lucian Moldovan, Hyunmin Kim, Diana M. Cittelly, 俊介小野, 周吉平山, Kai Pu, Kian Behbakht, Matthew J. Sikora, Benjamin G. Bitler	2019	74
15	BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer Cancer Research ·Yuhki Yokoyama, Hengrui Zhu, Jeong Heon Lee, Andrew V. Kossenkov, Sherry Y. Wu, Jayamanna Wickramasinghe, Xiangfan Yin, Katherine C. Palozola, Alessandro Gardini, Louise C. Showe, Kenneth S. Zaret, Qin Liu, David W. Speicher, José R. Conejo-García, James E. Bradner, Zhiguo Zhang, Anil K. Sood, Tamás Ördög, Benjamin G. Bitler, Rugang Zhang	2016	116
16	NF-YA Underlies EZH2 Upregulation and Is Essential for Proliferation of Human Epithelial Ovarian Cancer Cells Molecular Cancer Research ·Azat Garipov, Hua Li, Benjamin G. Bitler, Roshan J. Thapa, Siddharth Balachandran, Rugang Zhang	2013	51
17	MUC1 Drives c-Met–Dependent Migration and Scattering Molecular Cancer Research ·Demslben, Benjamin G. Bitler, 王于仨 WANG Yusa, F Tuma, Joyce A. Schroeder	2012	10
18	Wnt5a Suppresses Epithelial Ovarian Cancer by Promoting Cellular Senescence Cancer Research ·Benjamin G. Bitler, Karen Lottis, Hua Li, Qi Cai, Hong Wu, Hua Xiang, Tianyu Li, Michael J. Birrer, Andrew K. Godwin, Paul Cairns, Rugang Zhang	2011	85
19	ALDH1A1 Is a Novel EZH2 Target Gene in Epithelial Ovarian Cancer Identified by Genome-Wide Approaches Cancer Prevention Research ·Hua Li, Benjamin G. Bitler, Vinod Vathipadiekal, Solomon Adebayo, Michael Slifker, Caretha L. Creasy, Peter J. Tummino, Paul Cairns, Michael J. Birrer, Rugang Zhang	2011	44
20	Intracellular MUC1 Peptides Inhibit Cancer Progression Clinical Cancer Research ·Benjamin G. Bitler, Ina Menzl, P K Rajbhandari, Barbara Sands, Wendy Knowlton, Andrew C. Chang, Joyce A. Schroeder	2008	59

About Benjamin G. Bitler

Benjamin G. Bitler is a scholar working on Reproductive Medicine, Biological Psychiatry, Cancer Research, Oncology and Molecular Biology, having authored 100 papers that have together received 3.9k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (17 papers), PARP inhibition in cancer therapy (14 papers), Epigenetics and DNA Methylation (14 papers), Chromatin Remodeling and Cancer (10 papers), RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (9 papers), Cancer Mechanisms and Therapy (9 papers) and Genomics and Chromatin Dynamics (8 papers). The work is most often cited by research in Cancer Research (759 citations), Reproductive Medicine (353 citations), Molecular Biology (2.8k citations), Oncology (1.1k citations) and Pathology and Forensic Medicine (441 citations). Benjamin G. Bitler has collaborated with scholars based in United States, Russia and Mexico. Frequent co-authors include Rugang Zhang, Andrew V. Kossenkov, Katherine M. Aird, José R. Conejo-García, David W. Speicher, Kian Behbakht, Joyce A. Schroeder, Zachary L. Watson, Azat Garipov and Hengrui Zhu. Their work appears in journals such as Molecular Cancer Research, Gynecologic Oncology, Cell Reports, Molecular Carcinogenesis and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact